Sei Investments CO Aclaris Therapeutics, Inc. Transaction History

Sei Investments CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $6,980 - $23,135	-3,277 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.63 - $7.84 $60,297 - $83,966	-10,710 Reduced 76.57%	3,277 $18,000
Q4 2018 Feb 13, 2019	BUY	$6.3 - $15.4 $87,891 - $214,845	13,951 Added 38752.78%	13,987 $103,000
Q3 2018 Nov 08, 2018	BUY	$14.38 - $20.89 $503 - $731	35 Added 3500.0%	36 $0
Q2 2018 Aug 03, 2018	SELL	$16.46 - $20.33 $17,250 - $21,305	-1,048 Reduced 99.9%	1 $0
Q1 2018 May 11, 2018	BUY	$17.08 - $25.64 $2,886 - $4,333	169 Added 19.2%	1,049 $18,000
Q4 2017 Feb 08, 2018	SELL	$21.47 - $27.8 $158,684 - $205,469	-7,391 Reduced 89.36%	880 $22,000
Q3 2017 Nov 06, 2017	BUY	$23.02 - $28.8 $190,398 - $238,204	8,271	8,271 $214,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $271M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.